Immuron (IMRN) Net Income towards Common Stockholders (2016 - 2024)

Immuron's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$1.6 million for Q4 2024.

• In Q4 2024, Net Income towards Common Stockholders rose 21.49% year-over-year to -$1.6 million; the TTM figure through Sep 2025 stood at -$1.6 million (up 21.49% YoY), while the FY2025 annual figure was -$3.4 million, up 25.67% from the prior year.
• Net Income towards Common Stockholders for Q4 2024 stood at -$1.6 million, up from -$2.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$13260.2 in Q4 2021, with the low at -$2.1 million in Q4 2023.
• The 5-year median for Net Income towards Common Stockholders is -$795595.5 (2022), against an average of -$893766.8.
• The sharpest annual moves came in 2021 and 2022: Net Income towards Common Stockholders jumped 76.89% in 2021, then slumped 2558.11% in 2022.
• Immuron's Net Income towards Common Stockholders stood at -$57387.7 in 2020, then surged by 76.89% to -$13260.2 in 2021, then plunged by 2558.11% to -$352470.5 in 2022, then tumbled by 488.19% to -$2.1 million in 2023, then gained by 21.49% to -$1.6 million in 2024.
• Business Quant data shows IMRN's Net Income towards Common Stockholders at -$1.6 million in Q4 2024, -$2.1 million in Q4 2023, and -$1.2 million in Q2 2023.